sulfinpyrazone has been researched along with Remission, Spontaneous in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with thrombotic thrombocytopenic purpura were seen." | 1.26 | Platelet-latelet-. ( Bozdech, MJ; Crowell, EB; Eckel, RH; Waterhouse, BE, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckel, RH | 1 |
| Crowell, EB | 1 |
| Waterhouse, BE | 1 |
| Bozdech, MJ | 1 |
1 other study available for sulfinpyrazone and Remission, Spontaneous
| Article | Year |
|---|---|
Platelet-latelet-.
Topics: Adult; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Female; Humans; Methylprednisol | 1977 |